Cancer stem cells: a challenging paradigm for designing targeted drug therapies

Drug Discovery Today

Volumn 20, Issue 10, 2015, Pages 1205-1216

  Khan, Ishaq N ^a   Al Karim, Saleh ^a   Bora, Roop S ^a,b   Chaudhary, Adeel G ^a   Saini, Kulvinder S ^a,b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b ETERNAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; MICRORNA;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STEM CELL; DRUG TARGETING; EMBRYONIC STEM CELL; FEASIBILITY STUDY; GENE TARGETING; HUMAN; INTRACELLULAR SIGNALING; METASTASIS; MULTIDRUG RESISTANCE; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; RNA INTERFERENCE; STEM CELL NICHE; TUMOR MICROENVIRONMENT; ANIMAL; DRUG DESIGN; DRUG RESISTANCE; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DESIGN; DRUG RESISTANCE, NEOPLASM; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 84944447246     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.06.013     Document Type: Review

References (160)

1. T. Reya, and et al. Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111
2. L. Li, and W.B. Neaves Normal stem cells and cancer stem cells: the niche matters Cancer Res. 66 2006 4553 4557
3. F. Li, and et al. Beyond tumorigenesis: cancer stem cells in metastasis Cell Res. 17 2007 3 14
4. J. Gil, and et al. Cancer stem cells: the theory and perspectives in cancer therapy J. Appl. Genet. 49 2008 193 199
5. H.G. Liu, and et al. Cancer stem cell subsets and their relationships J. Transl. Med. 9 2011 1479 5876
6. S.A. Unai, and et al. Embryonic and cancer stem cells: two views of the same landscape C. Atwood, Embryonic Stem Cells: Recent Advances in Pluripotent Stem Cell-based Regenerative Medicine 2011 Intech 371 398
7. J.A. Magee, and et al. Cancer stem cells: impact, heterogeneity, and uncertainty Cancer Cell 21 2012 283 296
8. H.U.S. Brianna Cancer stem cells: a review of the literature and the implications in head and neck cancer J. Cancer Res. Updates 2 2013 186 193
9. D. Friedmann-Morvinski, and I.M. Verma Dedifferentiation and reprogramming: origins of cancer stem cells EMBO Rep. 15 2014 244 253
10. P.B. Gupta, and et al. Cancer stem cells: mirage or reality? Nat. Med. 15 2009 1010 1012
11. N. Takebe, and et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update Nat. Rev. Clin. Oncol. 2015 10.1038/nrclinonc.2015.61 Published online April 7, 2015
12. C.E. Meacham, and S.J. Morrison Tumor heterogeneity and cancer cell plasticity Nature 501 2013 328 337
13. N. Oishi, and et al. Molecular biology of liver cancer stem cells Liver Cancer 3 2014 71 84
14. D. Hussein, and et al. Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion Neurol. Oncol. 13 2011 70 83
15. R. Scatena, and et al. Advances in Cancer Stem Cell Biology 2012 Springer
16. I. Khan, and et al. Initial characterization of drug resistant cancer stem cells isolated from primary brain tumors (astrocytoma) cell lines generated from Saudi patients BMC Genomics Suppl. 2 2014 53
17. O. Dreesen, and A.H. Brivanlou Signaling pathways in cancer and embryonic stem cells Stem Cell Rev. 3 2007 7 17
18. S. Roy, and A. Majumdar Signaling in colon cancer stem cells J. Mol. Signal. 7 2012 11
19. U. Karsten, and S. Goletz What makes cancer stem cell markers different? Springerplus 2 2013 1 8
20. S. Sell Cellular origin of cancer: dedifferentiation or stem cell maturation arrest? Environ. Health Perspect. 1 Suppl. 5 1993 15
21. T. Brabletz, and et al. Migrating cancer stem cells: an integrated concept of malignant tumor progression Nat. Rev. Cancer 5 2005 744 749
22. NIH Stem Cell Information 2013 National Institutes of Health
23. I. Espinoza, and L. Miele Deadly crosstalk: notch signaling at the intersection of EMT and cancer stem cells Cancer Lett. 341 2013 41 45
24. P.J. Donovan The germ cell-the mother of all stem cells Int. J. Dev. Biol. 42 1998 1043 1050
25. M.Z. Ratajczak, and et al. The embryonic rest hypothesis of cancer development: an old XIX century theory revisited J. Cancer Stem Cell Res. 2 2014 e1001
26. C. Liu, and et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 Nat. Med. 17 2011 211 215
27. I.A. Silva, and et al. Aldehyde dehydrogenase in combination with CD1defines angiogenic ovarian cancer stem cells that portend poor patient survival Cancer Res. 71 2011 3991 4001
28. C. Naujokat, and R. Steinhart Salinomycin as a drug for targeting human cancer stem cells J. Biomed. Biotechnol. 2012 2012 950658
29. F. Iacopino, and et al. Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones PLoS ONE 9 2014 e105166
30. M. Al-Hajj, and et al. Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U. S. A. 100 2003 3983 3988
31. C. Ginestier, and et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567
32. S. Pece, and et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content Cell 140 2010 62 73
33. Y. Miyoshi, and et al. Basal-like subtype and BRCA1 dysfunction in breast cancers Int. J. Clin. Oncol. 13 2008 395 400
34. S. Deng, and et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers PLoS ONE 5 2010 0010277
35. S.K. Singh, and et al. Identification of human brain tumor initiating cells Nature 432 2004 396 401
36. M.J. Son, and et al. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma Cell Stem Cell 4 2009 440 452
37. S. Mazzoleni, and et al. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis Cancer Res. 70 2010 7500 7513
38. J. Anido, and et al. TGF-beta receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma Cancer Cell 18 2010 655 668
39. C.A. O'Brien, and et al. A human colon cancer cell capable of initiating tumor growth in immunodeficient mice Nature 445 2007 106 110
40. P. Dalerba, and et al. Phenotypic characterization of human colorectal cancer stem cells Proc. Natl. Acad. Sci. U. S. A. 104 2007 10158 10163
41. B.J. Wilson, and et al. ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients Cancer Res. 71 2011 5307 5316
42. K. Kemper, and et al. The AC1epitope, but not the CD1protein, is lost upon cancer stem cell differentiation Cancer Res. 70 2010 719 729
43. A. Eramo, and et al. Identification and expansion of the tumorigenic lung cancer stem cell population Cell Death Differ. 15 2008 504 514
44. J.P. Sullivan, and et al. Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy Cancer Metastasis Rev. 29 2010 61 72
45. E.L. Leung, and et al. Non-small cell lung cancer cells expressing CDare enriched for stem cell-like properties PLoS ONE 5 2010 0014062
46. M. Damelin, and et al. Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells Cancer Res. 71 2011 4236 4246
47. S. Tanaka Cancer stem cells as therapeutic targets of hepato-biliary-pancreatic cancers J. Hepatobiliary Pancreat. Sci. 14 2015 248
48. L.C. Stevens The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos Dev. Biol. 21 1970 364 382
49. J. Chen, and et al. A restricted cell population propagates glioblastoma growth after chemotherapy Nature 488 2012 522 526
50. G. Driessens, and et al. Defining the mode of tumor growth by clonal analysis Nature 488 2012 527 530
51. Y. Guo, and et al. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas Histopathology 59 2011 763 775
52. W. Zhao, and et al. Embryonic stem cell markers Molecules 17 2012 6196 6236
53. J.D. Holland, and et al. Wnt signaling in stem and cancer stem cells Curr. Opin. Cell Biol. 25 2013 254 264
54. J. Fujikura, and et al. Differentiation of embryonic stem cells is induced by GATA factors Genes Dev. 16 2002 784 789
55. H. Rippon, and A. Bishop Embryonic stem cells Cell Prolif. 37 2004 23 34
56. M. Genander, and J. Frisén Ephrins and Eph receptors in stem cells and cancer Curr. Opin. Cell Biol. 22 2010 611 616
57. J. Kim, and et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs Cell 143 2010 313 324
58. N. Smart, and P.R. Riley The stem cell movement Circulat. Res. 102 2008 1155 1168
59. F. Islam, and et al. Cancer stem cells in oesophageal squamous cell carcinoma: identification, prognostic and treatment perspectives Crit. Rev. Oncol. Hematol. 16 2015 10.1016/j.critrevonc.2015.04.007 Published online April 2015
60. A. Singh, and J. Settleman EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Oncogene 29 2010 4741 4751
61. K. Pavlov, and et al. GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma Dig. Liver Dis. 47 2015 73 80
62. R. Chhabra Cervical cancer stem cells: opportunities and challenges J. Cancer Res. Clin. Oncol. 7 2015 10.1007/s00432-014-1905-y Published online January 2015
63. Y. Zhang, and et al. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response Oncogene 31 2012 1055 1064
64. M.R. Emani, and et al. The L1TD1 protein interactome reveals the importance of post-transcriptional regulation in human pluripotency Stem Cell Rep. 4 2015 519 528
65. H. Peterson, and et al. From structural to molecular systems biology: experimental and computational approaches to unravel mechanisms of kinase activity regulation in cancer and neurodegeneration: qualitative modeling identifies IL-as a novel regulator in maintaining self-renewal in human pluripotent stem cells Front. Physiol. 4 2013 303
66. C.Y. Dong, and et al. Twist-1, a novel regulator of hematopoietic stem cell self-renewal and myeloid lineage development Stem Cells 32 2014 3173 3182
67. I. Malanchi, and et al. Interactions between cancer stem cells and their niche govern metastatic colonization Nature 481 2012 85 89
68. G. Keller Embryonic stem cell differentiation: emergence of a new era in biology and medicine Genes Dev. 19 2005 1129 1155
69. N. Korin, and S. Levenberg Engineering human embryonic stem cell differentiation Biotechnol. Genet. Eng. Rev. 24 2007 243 262
70. C. Darini, and et al. Targeting cancer stem cells expressing an embryonic signature with anti-proteases to decrease their tumor potential Cell Death Dis. 4 2013 e706
71. 2+ channels in mouse embryonic stem cells: modulation during cell cycle and contribution to self-renewal Am. J. Physiol. Cell Physiol. 302 2012 C494 C504
72. C. Wiese, and et al. Nestin expression: a property of multi-lineage progenitor cells? Cell Mol. Life Sci. 61 2004 2510 2522
73. A. HamaI, and et al. Cancer stem cells and autophagy: facts and perspectives J. Cancer Stem Cell Res. 2 2014 e1005
74. Y. Nakanishi, and et al. Dclk1 distinguishes between tumor and normal stem cells in the intestine Nat. Genet. 45 2013 98 103
75. J.M. Bailey, and et al. DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer Gastroenterology 146 2014 245 256
76. R.I. Fernando, and et al. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells Cancer Res. 71 2011 5296 5306
77. S.Y. Kim, and et al. Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells Cell Signal 25 2013 961 969
78. N.R. West, and et al. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer Oncogene 33 2014 1485 1494
79. M. Gassenmaier, and et al. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis Stem Cells 31 2013 1467 1476
80. T. Fulmer Targeting chemokines in breast cancer SciBX 3 2010 4
81. Y. Feng, and et al. EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis Cell Prolif. 45 2012 413 419
82. K.R. Levental, and et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling Cell 139 2009 891 906
83. J.M. Northcott, and et al. Fighting the force: potential of homeobox genes for tumor microenvironment regulation Biochim. Biophys. Acta Rev. Cancer 1855 2015 248 253
84. P.C. Hermann, and et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 2007 313 323
85. E. Charafe-Jauffret, and et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature Cancer Res. 69 2009 1302 1313
86. R. Pang, and et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer Cell Stem Cell 6 2010 603 615
87. F.G. Giancotti Mechanisms governing metastatic dormancy and reactivation Cell 155 2013 750 764
88. N. Takebe, and et al. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways Nat. Rev. Clin. Oncol. 8 2011 97 106
89. F. Takahashi-Yanaga, and M. Kahn Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin. Cancer Res. 16 2010 3153 3162
90. X. Jiang, and et al. Inactivating mutations of RNFconfer Wnt dependency in pancreatic ductal adenocarcinoma Proc. Natl. Acad. Sci. U. S. A. 110 2013 12649 12654
91. A. Pannuti, and et al. Targeting Notch to target cancer stem cells Clin. Cancer Res. 16 2010 3141 3152
92. E.M. O'Reilly, and et al. Final results of phase Ib of anticancer stem cell antibody tarextumab (OMP-59R5, TRXT, anti-Notch 2/3) in combination with nab-paclitaxel and gemcitabine (Nab-P+ Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC) ASCO Annu. Meet. Proc. 33 2015 278
93. L.M. Hoffman, and et al. Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study Childs Nerv. Syst. 2015 Published online May 1, 2015. http://dx.doi.org/10.1007/s00381-015-2725-3
94. N. Basset-Seguin, and et al. Efficacy of Hedgehog pathway inhibitors in basal cell carcinoma Mol. Cancer Ther. 14 2015 633 641
95. C. Cai, and X. Zhu The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer Mol. Med. Rep. 5 2012 1191 1196
96. L. Vermeulen, and et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment Nat. Cell Biol. 12 2010 468 476
97. E.M. de Sousa, and et al. Targeting Wnt signaling in colon cancer stem cells Clin. Cancer Res. 17 2011 647 653
98. Y. Teng, and et al. Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cells Biochem. Biophys. Res. Commun. 392 2010 373 379
99. Z. Song, and et al. Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer PLoS ONE 6 2011 e17687
100. J.P. Medema, and L. Vermeulen Microenvironmental regulation of stem cells in intestinal homeostasis and cancer Nature 474 2011 318 326
101. M. Rodova, and et al. Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal PLoS ONE 7 2012 e46083
102. M.A. LaBarge The difficulty of targeting cancer stem cell niches Clin. Cancer Res. 16 2010 3121 3129
103. L. Lacerda, and et al. The role of tumor initiating cells in drug resistance of breast cancer: implications for future therapeutic approaches Drug Resist. Updat. 13 2010 99 108
104. L. Jin, and et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells Nat. Med. 12 2006 1167 1174
105. L. Jin, and et al. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells Cell Stem Cell 5 2009 31 42
106. Y. Kikushige, and et al. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells Cell Stem Cell 7 2010 708 717
107. T.J. Curiel Immunotherapy: a useful strategy to help combat multidrug resistance Drug Resist. Updat. 15 2012 106 113
108. N. Mehra, and et al. Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases Clin. Cancer Res. 12 2006 4859 4866
109. E.H. Lin, and et al. Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence Cancer 110 2007 534 542
110. C.H. Wang, and et al. Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody Nanomedicine 7 2011 69 79
111. J. Diessner, and et al. Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1) Cell Death Dis. 27 2014 115
112. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
113. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
114. J. Lu, and et al. MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
115. S. Volinia, and et al. A microRNA expression signature of human solid tumors defines cancer gene targets Proc. Natl. Acad. Sci. U. S. A. 103 2006 2257 2261
116. G.A. Calin, and et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc. Natl. Acad. Sci. U. S. A. 101 2004 2999 3004
117. A. Esquela-Kerscher, and F.J. Slack Oncomirs: microRNAs with a role in cancer Nat. Rev. Cancer 6 2006 259 269
118. A.L. Kasinski, and F.J. Slack Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy Nat. Rev. Cancer 11 2011 849 864
119. R. Spizzo, and et al. SnapShot: microRNAs in cancer Cell 137 2009 586
120. S. Volinia, and et al. Reprogramming of miRNA networks in cancer and leukemia Genome Res. 20 2010 589 599
121. P.P. Medina, and et al. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma Nature 467 2010 86 90
122. M.E. Hatley, and et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21 Cancer Cell 18 2010 282 293
123. L.B. Frankel, and et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells J. Biol. Chem. 283 2008 1026 1033
124. F. Yu, and et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells Cell 131 2007 1109 1123
125. C.D. Johnson, and et al. The let-7 microRNA represses cell proliferation pathways in human cells Cancer Res. 67 2007 7713 7722
126. M.S. Kumar, and et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family Proc. Natl. Acad. Sci. U. S. A. 105 2008 3903 3908
127. D. Barh, and et al. MicroRNA let-7: an emerging next-generation cancer therapeutic Curr. Oncol. 17 2010 70 80
128. F. Yu, and et al. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells Oncogene 29 2010 4194 4204
129. Y. Zhu, and et al. Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5 Clin. Cancer Res. 17 2011 7105 7115
130. F. Yu, and et al. MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells J. Biol. Chem. 287 2012 465 473
131. P. Bu, and et al. A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells Cell Stem Cell 12 2013 602 615
132. M. Scherr, and et al. Inhibition of GM-CSF receptor function by stable RNA interference in a NOD/SCID mouse hematopoietic stem cell transplantation model Oligonucleotides 13 2003 353 363
133. L.L. Zhou, and et al. AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells J. Exp. Med. 205 2008 2657 2671
134. S. Bao, and et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 2006 756 760
135. L. Patrawala, and et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic Cancer Res. 65 2005 6207 6219
136. J. Wang, and et al. siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth Mol. Biol. Rep. 39 2012 2497 2503
137. S. Ma, and et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells Gastroenterology 132 2007 2542 2556
138. E.H. Huang, and et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis Cancer Res. 69 2009 3382 3389
139. J.L. Dembinski, and S. Krauss Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma Clin. Exp. Metastasis 26 2009 611 623
140. D. Ucar, and et al. Aldehyde dehydrogenase activity as a functional marker for lung cancer Chem. Biol. Interact. 178 2009 48 55
141. E. Charafe-Jauffret, and et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer Clin. Cancer Res. 16 2010 45 55
142. A. Yokota, and et al. GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity Int. Immunol. 21 2009 361 377
143. Y.C. Wang, and et al. ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome Am. J. Pathol. 180 2012 1159 1169
144. E. Meng, and et al. ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling PLoS ONE 9 2014 e107142
145. C.N. Landen Jr., and et al. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer Mol. Cancer Ther. 9 2010 3186 3199
146. ClinicalTrials.gov Clinical Studies of Human Participants Conducted Around the World 2015 US National Institutes of Health
147. Genus Oncology MUC1-C and Cancer Stem Cells 2015 Genus Oncology
148. J. Kaiser The cancer stem cell gamble Science 347 2015 226 229
149. D. Stroopinsky, and et al. MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells Cancer Res. 73 2013 5569 5579
150. M. Alam, and et al. MUC1-C oncoprotein activates ERK→ C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells J. Biol. Chem. 288 2013 30892 30903
151. M. Alam, and et al. MUC1-C induces the LIN28B→ LET-7→ HMGA2 axis to regulate self-renewal in NSCLC Mol. Cancer Res. 13 2014 449 460
152. M. Alam, and et al. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells Oncotarget 5 2014 2622 2634
153. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
154. R.S. Bora, and et al. RNA interference therapeutics for cancer: challenges and opportunities (review) Mol. Med. Rep. 6 2012 9 15
155. J.A. MacDiarmid, and et al. Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug Nat. Biotechnol. 27 2009 643 651
156. J.A. MacDiarmid, and H. Brahmbhatt Minicells: versatile vectors for targeted drug or si/shRNA cancer therapy Curr. Opin. Biotechnol. 22 2011 909 916
157. EnGeneIC. (2009) Gene Silencing: The biggest threat to long-term survival of cancer patients is multi-drug resistance. EnGeneIC Cancer Research Foundation, www.engeneic.com.
158. P. Grover, and et al. Circulating tumor cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research Ann. Oncol. 25 2014 1506 1516
159. J.S.M. Sabir, and et al. Role of toxicogenomics in the development of safe, efficacious and novel anti-microbial therapies Infect. Disord. Drug Targets 13 2013 206 214
160. N.J. Schork Personalized medicine: time for one-person trials Nature 520 2015 609 611